CD274 and non-small cell lung carcinoma: These results suggest that the BRICS strategy, comprising stereotactic body radiation therapy (SBRT), low-dose chemotherapy, PD-1/PD-L1 inhibitors, and high-dose probiotics, may represent a breakthrough in overcoming the therapeutic bottleneck for PD-L1-negative NSCLC.